Ticker	Volume	Price	Price Delta
DJIA	15,354.40	+121.18	0.80%
S&P 500	1,667.47	+17.00	1.03%
Nasdaq	3,498.97	+33.72	0.97%

Ticker

Volume

Price

Price Delta

DJIA

15,354.40

+121.18

0.80%

S&P 500

1,667.47

+17.00

1.03%

Nasdaq

3,498.97

+33.72

0.97%

Ticker	Volume	Price	Price Delta
STOXX 50	2,822.51	+4.52	0.16%
FTSE 100	6,735.25	+12.19	0.18%
DAX	8,444.20	+46.20	0.55%

Ticker

Volume

Price

Price Delta

STOXX 50

2,822.51

+4.52

0.16%

FTSE 100

6,735.25

+12.19

0.18%

DAX

8,444.20

+46.20

0.55%

Ticker	Volume	Price	Price Delta
Nikkei	15,360.80	+222.69	1.47%
Hang Seng	23,493.00	+410.35	1.78%
S&P/ASX 200	5,209.04	+28.26	0.55%

Ticker

Volume

Price

Price Delta

Nikkei

15,360.80

+222.69

1.47%

Hang Seng

23,493.00

+410.35

1.78%

S&P/ASX 200

5,209.04

+28.26

0.55%

Verenium Considering Buyout Offer as Option to Refinance Debt

By Reed Landberg - 2012-03-05T13:25:35Z

Verenium Corp. (VRNM), a maker of enzymes used for making biofuels, said it’s considering a buyout offer from more than one company as part of its effort to refinance its debt.

The San Diego based company informed holders of $34.9 million in convertible bonds that it will repurchase the notes on April 2 if it has sufficient cash to complete the transaction, according to a statement on PR Newswire today.

Verenium also is considering issuing securities to raise the cash necessary for paying the bondholders. It didn’t name the bidders offering the buy the company or say what the terms of the purchase would be, noting instead that there’s no assurance a definitive agreement will be struck.

To contact the editor responsible for this story: Reed Landberg at landberg@bloomberg.net

More News:

Environment

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.